MUTAGENIC ACTIVATION OF AFLATOXIN-B1 BY P-450 HFLA IN HUMAN-FETAL LIVERS

被引：41

作者：

KITADA, M

TANEDA, M

OHI, H

KOMORI, M

ITAHASHI, K

NAGAO, M

KAMATAKI, T

机构：

[1] KAWASAKI SEITETSU HOSP,CHIBA 280,JAPAN

[2] NATL CANC CTR,RES INST,TOKYO 104,JAPAN

来源：

MUTATION RESEARCH | 1989年 / 227卷 / 01期

关键词：

D O I：

10.1016/0165-7992(89)90068-7

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：53 / 58

页数：6

共 25 条

[1]

BLANCK A, 1980, BIOCH BIOPHYSICS REG, P93

[2]

CONNEY AH, 1982, CANCER RES, V42, P4875

[3]

CRESTEIL T, 1982, PEDIATR PHARMACOL, V2, P199

[4] ESTIMATION OF ISOZYMES OF MICROSOMAL CYTOCHROME-P-450 IN RATS, RABBITS, AND HUMANS USING IMMUNOCHEMICAL STAINING COUPLED WITH SODIUM DODECYL-SULFATE POLYACRYLAMIDE-GEL ELECTROPHORESIS [J].

GUENGERICH, FP ;

WANG, P ;

DAVIDSON, NK .

BIOCHEMISTRY, 1982, 21 (07) :1698-1706

[5]

GUENGERICH FP, 1988, CANCER RES, V48, P2946

[6] MUTAGENIC ACTIVATION OF AFLATOXIN-B1 BY SEVERAL FORMS OF PURIFIED CYTOCHROME-P-450 [J].

ISHII, K ;

MAEDA, K ;

KAMATAKI, T ;

KATO, R .

MUTATION RESEARCH, 1986, 174 (02) :85-88

[7] DRUG-METABOLISM BY THE HUMAN-FETUS [J].

JUCHAU, MR ;

CHAO, ST ;

OMIECINSKI, CJ .

CLINICAL PHARMACOKINETICS, 1980, 5 (04) :320-339

[8] PARTIAL-PURIFICATION AND CHARACTERIZATION OF CYTOCHROME-P-450 RESPONSIBLE FOR THE OCCURRENCE OF SEX DIFFERENCE IN DRUG-METABOLISM IN THE RAT [J].

KAMATAKI, T ;

MAEDA, K ;

YAMAZOE, Y ;

NAGAI, T ;

KATO, R .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 103 (01) :1-7

[9]

KAMATAKI T, 1983, MOL PHARMACOL, V24, P246

[10] METABOLIC-ACTIVATION OF MUTAGENIC HETEROCYLIC AROMATIC-AMINES FROM PROTEIN PYROLYSATES [J].

KATO, R .

CRC CRITICAL REVIEWS IN TOXICOLOGY, 1986, 16 (04) :307-348

← 1 2 3 →